SCANNING MARKETS…
INDUSTRY DEEP-DIVE
🏭
Pharmaceuticals Major
MOST VOLATILE
Accuracy (30D)
50.0%
14 recent events
Gap PnL (Fixed)
+$657.82
$100 base
Gap Balance (Cmp)
+$129.51
Compounded
Post PnL (Fixed)
-$2,522.12
$100 base
Post Bal (Cmp)
+$24.80
Compounded
📈 Group Equity Curve
🧠 AI Sentiment
🔒
Locked
⚡ LIVE RADAR EXECUTION DETECTED (4 TRADES)
PRO ONLY 🔒| Asset | Signal | Entry | Live PnL | Action |
|---|---|---|---|---|
| $FAE.MC | BUY x20 | $1.08540 | +8.40% | LIVE |
| $VNDA | BUY x20 | $1.08540 | +8.40% | LIVE |
| $MAZE | BUY x20 | $1.08540 | +8.40% | LIVE |
🔒
4 Live Trades Active in this Group
Our quantitative engine is currently trading assets in this segment. Real-time entries, leverages, and Trailing Stops are restricted to PRO members.
UNLOCK LIVE POSITIONS ⚡⏳ Next Opportunities in this Group
| Asset | Date | Timing | Action |
|---|---|---|---|
| Oct 30, 2026 | Before Open (08:00) | ANALYZE → | |
| Oct 30, 2026 | Before Open (08:00) | ANALYZE → | |
| Nov 02, 2026 | After Close (21:00) | ANALYZE → | |
| Nov 02, 2026 | After Close (21:00) | ANALYZE → | |
 $NVCT Nuvectis Pharma Inc | Nov 03, 2026 | Before Open (07:00) | ANALYZE → |
🏢 Group Constituents List
| Asset ↕ | Events ↕ | Win Rate 🔒 | Net PnL 🔒 |
|---|---|---|---|
CTMX CytomX Therapeutics Inc
|
10 | 88%🔒 |
+$5000🔒 |
DERM Journey Medical Corp
|
10 | 88%🔒 |
+$5000🔒 |
VERU Veru Inc
|
9 | 88%🔒 |
+$5000🔒 |
PDSB PDS Biotechnology Corpora
|
9 | 88%🔒 |
+$5000🔒 |
TNYA Tenaya Therapeutics Inc
|
8 | 88%🔒 |
+$5000🔒 |
TPST Tempest Therapeutics Inc
|
8 | 88%🔒 |
+$5000🔒 |
RVPH Reviva Pharmaceuticals Ho
|
8 | 88%🔒 |
+$5000🔒 |
REC.MI Recordati
|
8 | 88%🔒 |
+$5000🔒 |
RZLT Rezolute Inc
|
7 | 88%🔒 |
+$5000🔒 |
LEGN Legend Biotech Corporatio
|
7 | 88%🔒 |
+$5000🔒 |
ETON Eton Pharmaceuticals Inc
|
7 | 88%🔒 |
+$5000🔒 |
SVRA Savara Inc
|
7 | 88%🔒 |
+$5000🔒 |
ORNBV.HE Orion Oyj Class B
|
7 | 88%🔒 |
+$5000🔒 |
INDP Intec Parent Inc
|
7 | 88%🔒 |
+$5000🔒 |
GRCE Grace Therapeutics Inc
|
7 | 88%🔒 |
+$5000🔒 |
HOWL Werewolf Therapeutics Inc
|
7 | 88%🔒 |
+$5000🔒 |
SAN.PA Sanofi
|
6 | 88%🔒 |
+$5000🔒 |
IRWD Ironwood Pharmaceuticals
|
6 | 88%🔒 |
+$5000🔒 |
TVTX Travere Therapeutics Inc
|
6 | 88%🔒 |
+$5000🔒 |
VRCA Verrica Pharmaceuticals I
|
6 | 88%🔒 |
+$5000🔒 |
IMRX Immuneering Corporation
|
6 | 88%🔒 |
+$5000🔒 |
NERV Minerva Neurosciences Inc
|
6 | 88%🔒 |
+$5000🔒 |
MGNX MacroGenics Inc
|
6 | 88%🔒 |
+$5000🔒 |
MBRX Moleculin Biotech Inc
|
6 | 88%🔒 |
+$5000🔒 |
SNGX Soligenix Inc
|
6 | 88%🔒 |
+$5000🔒 |
PFE.RTH Pfizer
|
6 | 88%🔒 |
+$5000🔒 |
INO Inovio Pharmaceuticals In
|
6 | 88%🔒 |
+$5000🔒 |
JAGX Jaguar Health Inc
|
6 | 88%🔒 |
+$5000🔒 |
KRRO Korro Bio Inc
|
6 | 88%🔒 |
+$5000🔒 |
GNLX Genelux Corporation
|
6 | 88%🔒 |
+$5000🔒 |
JNJ.RTH Johnson & Johnson
|
5 | 88%🔒 |
+$5000🔒 |
ENTA Enanta Pharmaceuticals In
|
5 | 88%🔒 |
+$5000🔒 |
VNDA Vanda Pharmaceuticals Inc
|
5 | 88%🔒 |
+$5000🔒 |
PHAT Phathom Pharmaceuticals I
|
5 | 88%🔒 |
+$5000🔒 |
NXTC NextCure Inc
|
5 | 88%🔒 |
+$5000🔒 |
KROS Keros Therapeutics Inc
|
5 | 88%🔒 |
+$5000🔒 |
DMRA Damora Therapeutics Inc
|
5 | 88%🔒 |
+$5000🔒 |
GOSS Gossamer Bio Inc
|
5 | 88%🔒 |
+$5000🔒 |
SPRY ARS Pharmaceuticals Inc
|
5 | 88%🔒 |
+$5000🔒 |
HROW Harrow Inc
|
5 | 88%🔒 |
+$5000🔒 |
MIST Milestone Pharmaceuticals
|
5 | 88%🔒 |
+$5000🔒 |
CRVS Corvus Pharmaceuticals In
|
5 | 88%🔒 |
+$5000🔒 |
MTNB Matinas BioPharma Holding
|
5 | 88%🔒 |
+$5000🔒 |
RIGL Rigel Pharmaceuticals Inc
|
5 | 88%🔒 |
+$5000🔒 |
OTLK Outlook Therapeutics Inc
|
5 | 88%🔒 |
+$5000🔒 |
SGMT Sagimet Biosciences Inc-A
|
5 | 88%🔒 |
+$5000🔒 |
SYRE Spyre Therapeutics Inc
|
5 | 88%🔒 |
+$5000🔒 |
RLMD🔒 #? Pullback Relmada Therapeutics Inc
|
5 | 88%🔒 |
+$5000🔒 |
IBRX ImmunityBio Inc
|
5 | 88%🔒 |
+$5000🔒 |
GPCR Structure Therapeutics In
|
5 | 88%🔒 |
+$5000🔒 |
GSK GlaxoSmithKline plc ADR
|
4 | 88%🔒 |
+$5000🔒 |
MDGL Madrigal Pharmaceuticals
|
4 | 88%🔒 |
+$5000🔒 |
KNSA Kiniksa Pharmaceuticals L
|
4 | 88%🔒 |
+$5000🔒 |
XENE Xenon Pharmaceuticals Inc
|
4 | 88%🔒 |
+$5000🔒 |
LXRX Lexicon Pharmaceuticals I
|
4 | 88%🔒 |
+$5000🔒 |
PBYI Puma Biotechnology Inc
|
4 | 88%🔒 |
+$5000🔒 |
CRBP Corbus Pharmaceuticals Ho
|
4 | 88%🔒 |
+$5000🔒 |
IDYA IDEAYA Biosciences Inc
|
4 | 88%🔒 |
+$5000🔒 |
FULC Fulcrum Therapeutics Inc
|
4 | 88%🔒 |
+$5000🔒 |
OVID Ovid Therapeutics Inc
|
4 | 88%🔒 |
+$5000🔒 |
ORIC ORIC Pharmaceuticals Inc
|
4 | 88%🔒 |
+$5000🔒 |
LFCR Lifecore Biomedical Inc
|
4 | 88%🔒 |
+$5000🔒 |
TRVN Trevena Inc
|
4 | 88%🔒 |
+$5000🔒 |
IRD Opus Genetics Inc
|
4 | 88%🔒 |
+$5000🔒 |
GNPX Genprex Inc
|
4 | 88%🔒 |
+$5000🔒 |
OLMA Olema Pharmaceuticals Inc
|
4 | 88%🔒 |
+$5000🔒 |
MRK.DE MERCK KGAA
|
4 | 88%🔒 |
+$5000🔒 |
PTN Palatin Technologies Inc
|
4 | 88%🔒 |
+$5000🔒 |
EYPT EyePoint Inc
|
4 | 88%🔒 |
+$5000🔒 |
PLX Protalix Biotherapeutics
|
4 | 88%🔒 |
+$5000🔒 |
LYRA Lyra Therapeutics Inc
|
4 | 88%🔒 |
+$5000🔒 |
IMMX Immix Biopharma Inc
|
4 | 88%🔒 |
+$5000🔒 |
MRK.RTH Merck & Co.
|
4 | 88%🔒 |
+$5000🔒 |
SOBI.ST Swedish Orphan Biovitrum
|
4 | 88%🔒 |
+$5000🔒 |
NKTR Nektar Therapeutics
|
4 | 88%🔒 |
+$5000🔒 |
ERAS Erasca Inc
|
4 | 88%🔒 |
+$5000🔒 |
KALA Kala Bio Inc
|
4 | 88%🔒 |
+$5000🔒 |
LENZ LENZ Therapeutics Inc
|
4 | 88%🔒 |
+$5000🔒 |
TARS Tarsus Pharmaceuticals In
|
4 | 88%🔒 |
+$5000🔒 |
NVO Novo-Nordisk A/S SPONS AD
|
3 | 88%🔒 |
+$5000🔒 |
MNKD MannKind Corp
|
3 | 88%🔒 |
+$5000🔒 |
ONC BeiGene Ltd-ADR
|
3 | 88%🔒 |
+$5000🔒 |
OCGN Ocugen Inc
|
3 | 88%🔒 |
+$5000🔒 |
TNXP Tonix Pharmaceuticals Hol
|
3 | 88%🔒 |
+$5000🔒 |
OMER Omeros Corp
|
3 | 88%🔒 |
+$5000🔒 |
IMTX Immatics NV
|
3 | 88%🔒 |
+$5000🔒 |
STRO Sutro Biopharma Inc
|
3 | 88%🔒 |
+$5000🔒 |
ZYME Zymeworks Inc
|
3 | 88%🔒 |
+$5000🔒 |
VRDN Viridian Therapeutics Inc
|
3 | 88%🔒 |
+$5000🔒 |
NOVO-B.CO Novo Nordisk B A/S
|
3 | 88%🔒 |
+$5000🔒 |
NYKD.OL Nykode Therapeutics ASA
|
3 | 88%🔒 |
+$5000🔒 |
GSK.L GlaxoSmithKline
|
3 | 88%🔒 |
+$5000🔒 |
INSM Insmed Incorporated
|
3 | 88%🔒 |
+$5000🔒 |
PRQR ProQR Therapeutics NV
|
3 | 88%🔒 |
+$5000🔒 |
RDY Dr. Reddys Laboratories L
|
3 | 88%🔒 |
+$5000🔒 |
LPCN Lipocine Inc
|
3 | 88%🔒 |
+$5000🔒 |
OCUL Ocular Therapeutix Inc
|
3 | 88%🔒 |
+$5000🔒 |
OKUR OnKure Therapeutics Inc
|
3 | 88%🔒 |
+$5000🔒 |
GYRE Gyre Therapeutics Inc
|
3 | 88%🔒 |
+$5000🔒 |
MAZE Maze Therapeutics Inc
|
3 | 88%🔒 |
+$5000🔒 |
DBV.PA DBV Technologies
|
3 | 88%🔒 |
+$5000🔒 |
RPRX Royalty Pharma PLC
|
2 | 88%🔒 |
+$5000🔒 |
IONS Ionis Pharmaceuticals
|
2 | 88%🔒 |
+$5000🔒 |
GHRS GH Research PLC
|
2 | 88%🔒 |
+$5000🔒 |
SCPX Scorpius Holdings Inc
|
2 | 88%🔒 |
+$5000🔒 |
EBS Emergent BioSolutions Inc
|
2 | 88%🔒 |
+$5000🔒 |
MLTX MoonLake Immunotherapeuti
|
2 | 88%🔒 |
+$5000🔒 |
TXMD TherapeuticsMD Inc
|
2 | 88%🔒 |
+$5000🔒 |
VKTX Viking Therapeutics Inc
|
2 | 88%🔒 |
+$5000🔒 |
NVS Novartis ADR
|
2 | 88%🔒 |
+$5000🔒 |
DFTX Definium Therapeutics Inc
|
2 | 88%🔒 |
+$5000🔒 |
HLN Haleon PLC-ADR
|
2 | 88%🔒 |
+$5000🔒 |
PRAX Praxis Precision Medicine
|
2 | 88%🔒 |
+$5000🔒 |
NAMS NewAmsterdam Pharma Compa
|
2 | 88%🔒 |
+$5000🔒 |
IMUX Immunic Inc
|
2 | 88%🔒 |
+$5000🔒 |
RYTM Rhythm Pharmaceuticals In
|
2 | 88%🔒 |
+$5000🔒 |
SCYX Scynexis Inc
|
2 | 88%🔒 |
+$5000🔒 |
NBP NovaBridge Biosciences
|
2 | 88%🔒 |
+$5000🔒 |
MIRM Mirum Pharmaceuticals Inc
|
2 | 88%🔒 |
+$5000🔒 |
FYB.DE FORMYCON AG
|
2 | 88%🔒 |
+$5000🔒 |
VISTN.OL Vistin Pharma ASA
|
2 | 88%🔒 |
+$5000🔒 |
RGC Regencell Bioscience Hold
|
2 | 88%🔒 |
+$5000🔒 |
FAE.MC Faes Farma S.A.
|
2 | 88%🔒 |
+$5000🔒 |
EGRX Eagle Pharmaceuticals Inc
|
1 | 88%🔒 |
+$5000🔒 |
EVLO Evelo Biosciences Inc
|
1 | 88%🔒 |
+$5000🔒 |
FRMM Forum Markets Inc
|
1 | 88%🔒 |
+$5000🔒 |
SNY Sanofi-ADR
|
1 | 88%🔒 |
+$5000🔒 |
OGEN Oragenics Inc
|
1 | 88%🔒 |
+$5000🔒 |
GRFS Grifols SA
|
1 | 88%🔒 |
+$5000🔒 |
GRF.MC Grifols SA
|
1 | 88%🔒 |
+$5000🔒 |
ZVRA Zevra Therapeutics Inc
|
1 | 88%🔒 |
+$5000🔒 |
VYNE VYNE Therapeutics INC
|
1 | 88%🔒 |
+$5000🔒 |
CRNX Crinetics Pharmaceuticals
|
1 | 88%🔒 |
+$5000🔒 |
|
NVCT Nuvectis Pharma Inc
|
1 | 88%🔒 |
+$5000🔒 |
TBPH Theravance Biopharma Inc
|
1 | 88%🔒 |
+$5000🔒 |
SYRS Syros Pharmaceuticals Inc
|
1 | 88%🔒 |
+$5000🔒 |
EOLS Evolus Inc
|
1 | 88%🔒 |
+$5000🔒 |
ZOMDF Zomedica Corp
|
1 | 88%🔒 |
+$5000🔒 |
RARE Ultragenyx Pharmaceutical
|
1 | 88%🔒 |
+$5000🔒 |
RGNX REGENXBIO Inc
|
1 | 88%🔒 |
+$5000🔒 |
ONCIN.OL Oncoinvent ASA
|
1 | 88%🔒 |
+$5000🔒 |
REGN.RTH Regeneron Pharmaceuticals
|
1 | 88%🔒 |
+$5000🔒 |
UCB.BR UCB SA
|
1 | 88%🔒 |
+$5000🔒 |
IPN.PA Ipsen SA
|
1 | 88%🔒 |
+$5000🔒 |
VETO.PA Vetoquinol SA
|
1 | 88%🔒 |
+$5000🔒 |
OSE.PA OSE Immunotherapeutics SA
|
1 | 88%🔒 |
+$5000🔒 |
TAK Takeda Pharmaceutical Co
|
1 | 88%🔒 |
+$5000🔒 |
🔒 The historical Win Rate and precise Net PnL of each constituent are strictly reserved for PRO Members.
Unlock Premium Metrics